Estrogen protects against vaginal transmission of simian immunodeficiency virus

Journal of Infectious Diseases

Volumn 182, Issue 3, 2000, Pages 708-715

  Smith, Stephen M ^a,b   Baskin, Gary B ^c   Marx, Preston A ^c,d,e  

^a ST MICHAEL S MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL; ESTROGEN; GESTAGEN; PROGESTERONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MACACA; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINITIS; VIRUS TRANSMISSION;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; MACACA MULATTA; MUCOUS MEMBRANE; OVARIECTOMY; PROGESTERONE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VAGINA;

EID: 0033823720     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315776     Document Type: Article

References (37)

1. Women and HIV: Epidemiology and global overview
2. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV
3. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: A community study from rural West Africa
4. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1
5. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: Results from a longitudinal study
6. Ultrastructure of the nonhuman primate vaginal mucosa: Epithelial changes during the menstrual cycle and pregnancy
7. Genital mucosal transmission of simian immunodeficiency virus: Animal model for heterosexual transmission of human immunodeficiency virus
8. Progesterone implants enhance SIV vaginal transmission and early virus load
9. Prevalence of genito-urinary symptoms in the late menopause
10. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
11. Diurnal steroid patterns during gestation in the rhesus macaque: Onset, daily variation, and the effects of dexamethasone treatment
12. Protection against vaginal SIV transmission with microencapsulated vaccine
13. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected macaques using branched DNA (bDNA) signal amplification assay
14. Performance characteristics of an enhanced SIV RNA bDNA assay with a quantification limit of 1,500 SIV RNA copies
15. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: Predictive value for disease progression
16. Inactivation of human immunodeficiency virus (HIV) by low pH and pepsin
17. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro
18. Vaginal transmission of SIV: Assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks
19. + T cells
20. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy
21. Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy
22. Postmenopausal vaginal atrophy and atrophic vaginitis
23. The vaginal epithelium in the postmenopause: Cytology, histology, and pH as methods of assessment
24. Estriol in the management of the menopause
25. Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse: A randomised, double-blind trial
26. The demography of menopause
27. Sexual function in a community sample of middle-aged women with partners: Effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors
28. Long acting methods of contraception
29. Contraceptive delivery in the developing world
30. Risk factors of HIV-1 infection among female prostitutes in Khon Kaen, Northeast Thailand
31. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
32. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition